NASD · Healthcare · Medical Devices · USA
Bruker Corp is a mid cap company (market value between $2 billion and $10 billion) in the Medical Devices industry.
Bruker Corp develops, manufactures, and distributes high-performance scientific instruments and analytical solutions for life and materials science research. The company operates four segments offering magnetic resonance, mass spectrometry, chromatography, X-ray, microscopy, and spectroscopy technologies serving academic institutions, pharmaceutical and biotechnology companies, and clinical laboratories worldwide.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Bruker Corp stock.
Overvalued: intrinsic value $17.03 per share, market price $55.37, margin of safety -225.1% (as of 2026-10-19).
Discounting its cash flows at 9.8% (average of 2 methods) values the shares at $17.03; the price of $55.37 is 225% above that value, and 74% of that value comes from beyond year five.
Leak Score: 26/100 on 10 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
46 more in this industry show a wider margin of safety.
BRKR is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 9.8% (average of 2 methods) values the shares at $17.03; the price of $55.37 is 225% above that value, and 74% of that value comes from beyond year five.
$17.03 per share (as of the 2026-10-19 close), against a market price of $55.37. That is a margin of safety of -225.1%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
26 out of 100, which we rate "On Watch", on 10 of 12 value investing signals.